Mechanisms of Antifungal Drug Resistance in Candida Dubliniensis

• Coleman DC , BennettDE, SullivanDJ et al.: Oral Candida in HIV infection and AIDS: new perspectives/new approaches.Crit. Rev. Microbiol.19(2) , 61–82 (1993).
   PubMed Web of Science ®Google Scholar
• Sullivan DJ , HenmanMC, MoranGP et al.: Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species.J. Med. Microbiol.44(6) , 399–408 (1996).
   PubMed Web of Science ®Google Scholar
• Kibbler CC , SeatonS, BarnesRA et al.: Management and outcome of bloodstream infections due to Candida species in England and Wales.J. Hosp. Infect.54(1) , 18–24 (2003).
   PubMed Web of Science ®Google Scholar
• Chakrabarti A , ChatterjeeSS, RaoKL et al.: Recent experience with fungaemia: change in species distribution and azole resistance.Scand. J. Infect. Dis.41(4) , 275–284 (2009).
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C : The changing face of epidemiology of invasive fungal disease in Europe.Mycoses52(3) , 197–205 (2009).
   PubMed Web of Science ®Google Scholar
• Sullivan DJ , WesternengTJ, HaynesKA, BennettDE, ColemanDC: Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.Microbiology141(7) , 1507–1521 (1995).
   PubMedGoogle Scholar
• Coleman DC , SullivanDJ, BennettDE, MoranGP, BarryHJ, ShanleyDB: Candidiasis: the emergence of a novel species, Candida dubliniensis.AIDS11(5) , 557–567 (1997).
   PubMed Web of Science ®Google Scholar
• Sullivan D , HaynesK, BilleJ et al.: Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals.J. Clin. Microbiol.35(4) , 960–964 (1997).
   PubMed Web of Science ®Google Scholar
• Coleman D , SullivanD, HarringtonB et al.: Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients.Oral Dis.2(S1) , S96–S101 (1997).
   Google Scholar
• Sullivan D , ColemanD: Candida dubliniensis: characteristics and identification.J. Clin. Microbiol.36(2) , 329–334 (1998).
   PubMed Web of Science ®Google Scholar
• Sullivan DJ , MoranG, DonnellyS et al.: Candida dubliniensis: an update.Rev. Iberoam. Micol.16(2) , 72–76 (1999).
   PubMedGoogle Scholar
• Polacheck I , StrahilevitzJ, SullivanD, DonnellyS, SalkinIF, ColemanDC: Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel.J. Clin. Microbiol.38(1) , 170–174 (2000).
   PubMed Web of Science ®Google Scholar
• Pontón J , RüchelR, ClemonsKV et al.: Emerging pathogens.Med. Mycol.38(S1) , 225–236 (2000).
   PubMed Web of Science ®Google Scholar
• Willis AM , CoulterWA, SullivanDJ et al.: Isolation of C. dubliniensis from insulin-using diabetes mellitus patients.J. Oral Pathol. Med.29(2) , 86–90 (2000).
   PubMed Web of Science ®Google Scholar
• Milan EP , de Laet Sant‘ Ana P, de Azevedo Melo AS et al.: Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients. Diagn. Microbiol. Infect. Dis.41(1–2) , 29–35 (2001).
   PubMed Web of Science ®Google Scholar
• Moragues MD , OmaetxebarriaMJ, ElguezabalN et al.: Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections.J. Clin. Microbiol.39(8) , 2999–3001 (2001).
   PubMed Web of Science ®Google Scholar
• Boyle BM , SullivanDJ, ForkinC, MulcahyF, KeaneCT, ColemanDC: Candida dubliniensis candidaemia in an HIV-positive patient in Ireland.Int. J. STD AIDS13(1) , 55–57 (2002).
   PubMed Web of Science ®Google Scholar
• Martinez M , López-RibotJL, KirkpatrickWR, CocoBJ, BachmannSP, PattersonTF: Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.J. Clin. Microbiol.40(9) , 3135–3139 (2002).
   PubMed Web of Science ®Google Scholar
• Gee SF , JolyS, SollDR et al.: Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.J. Clin. Microbiol.40(2) , 556–574 (2002).
   PubMed Web of Science ®Google Scholar
• Bagg J , SweeneyMP, LewisMA et al.: High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer.Palliat. Med.17(6) , 477–481 (2003).
   PubMed Web of Science ®Google Scholar
• Fotedar R , Al-HedaithySS: Candida dubliniensis at a university hospital in Saudi Arabia.J. Clin. Microbiol.41(5) , 1907–1911 (2003).
   PubMed Web of Science ®Google Scholar
• Montour L , TeyR, XuJ: Isolation of Candida dubliniensis in an aboriginal community in Ontario, Canada.J. Clin. Microbiol.41(7) , 3423–3426 (2003).
   PubMed Web of Science ®Google Scholar
• Silva V , CabreraM, DíazMC, AbarcaC, HermosillaG: Prevalence of Candida albicans serotypes in blood isolates in Chile, and first report of Candida dubliniensis candidemia.Rev. Iberoam. Micol.20(2) , 46–51 (2003).
   PubMedGoogle Scholar
• Yang CW , BarkhamTM, ChanFY, WangY: Prevalence of Candida species, including Candida dubliniensis, in Singapore.J. Clin. Microbiol.41(1) , 472–474 (2003).
   PubMed Web of Science ®Google Scholar
• Sullivan DJ , MoranGP, PinjonE et al.: Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.FEMS Yeast Res.4(4–5) , 369–376 (2004).
   PubMed Web of Science ®Google Scholar
• Binolfi A , BiasoliMS, LuqueAG, ToselloME, MagaróHM: High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina.Med. Mycol.43(5) , 431–437 (2005).
   PubMed Web of Science ®Google Scholar
• Carr MJ , ClarkeS, O‘ConnellF, SullivanDJ, ColemanDC, O‘ConnellB: First reported case of endocarditis caused by Candida dubliniensis.J. Clin. Microbiol.43(6) , 3023–3026 (2005).
   PubMed Web of Science ®Google Scholar
• Chan-Tack KM : Fatal Candida dubliniensis septicemia in a patient with AIDS.Clin. Infect. Dis.40(8) , 1209–1210 (2005).
   PubMed Web of Science ®Google Scholar
• Jabra-Rizk MA , JohnsonJK, ForrestG, MankesK, MeillerTF, VeneziaRA: Prevalence of Candida dubliniensis fungemia at a large teaching hospital.Clin. Infect. Dis.41(7) , 1064–1067 (2005).
   PubMed Web of Science ®Google Scholar
• Melkusovà S , LisalovàM, PavlìkP, BujdàkovàH: The first clinical isolates of Candida dubliniensis in Slovakia.Mycopathologia159(3) , 369–371(2005).
   PubMed Web of Science ®Google Scholar
• Mubareka S , VinhDC, SancheSE: Candida dubliniensis bloodstream infection: a fatal case in a lung transplant recipient.Transpl. Infect. Dis.7(3–4) , 146–149 (2005).
   PubMed Web of Science ®Google Scholar
• Sullivan DJ , MoranGP, ColemanDC: Candida dubliniensis: ten years on.FEMS Microbiol. Lett.253(1) , 9–17 (2005).
   PubMed Web of Science ®Google Scholar
• Tay ST , ChaiHC, NaSL, NgKP: Molecular subtyping of clinical isolates of Candida albicans and identification of Candida dubliniensis in Malaysia.Mycopathologia159(3) , 325–329 (2005).
   PubMed Web of Science ®Google Scholar
• Brito Gamboa A , MendozaM, FernándezA, DíazE: Detection of Candida dubliniensis in patients with candidiasis in Caracas, Venezuela.Rev. Iberoam. Micol.23(2) , 81–84 (2006).
   PubMedGoogle Scholar
• Tekeli A , AkanOA, KoyuncuE, DolapciI, UysalS: Initial Candida dubliniensis isolate in Candida spp. positive haemocultures in Turkey between 2001 and 2004.Mycoses49(1) , 60–64 (2006).
   PubMed Web of Science ®Google Scholar
• Erköse G , ErturanZ: Oral Candida colonization of human immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count.Mycoses50(6) , 485–490 (2007).
   PubMed Web of Science ®Google Scholar
• Jewtuchowicz VM , MujicaMT, BruscaMI et al.: Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.Oral Microbiol. Immunol.23(6) , 505–509 (2008).
   PubMedGoogle Scholar
• McManus BA , ColemanDC, MoranG et al.: Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans.J. Clin. Microbiol.46(2) , 652–664 (2008).
   PubMed Web of Science ®Google Scholar
• Alvarez MI , SuárezBL, CaicedoLD: Isolation of Candida dubliniensis for the first time in Cali, Colombia, and its identification with phenotyping methods.Mycopathologia167(1) , 19–24 (2009).
   PubMed Web of Science ®Google Scholar
• Chunchanur SK , NadgirSD, HaleshLH, PatilBS, KausarY, ChandrasekharMR: Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.Indian J. Pathol. Microbiol.52(4) , 501–504 (2009).
   PubMed Web of Science ®Google Scholar
• de Araújo Navas EA , InocêncioAC, AlmeidaJD et al.: Oral distribution of Candida species and presence of oral lesions in Brazilian leprosy patients under multidrug therapy.J. Oral Pathol. Med.38(10) , 764–767 (2009).
   PubMed Web of Science ®Google Scholar
• Gasparoto TH , DionísioTJ, de Oliveira CE et al.: Isolation of Candida dubliniensis from denture wearers. J. Med. Microbiol.58(7) , 959–962 (2009).
   PubMed Web of Science ®Google Scholar
• Khlif M , SellamiH, SellamiA et al.: Candida dubliniensis: first identification in Sfax Hospital, Tunisia.Mycoses52(2) , 171–175 (2009).
   PubMed Web of Science ®Google Scholar
• Song X , SunJ, St⊘reG, HansenBF, OlsenI: Colony morphologies, species, and biotypes of yeasts from thrush and denture stomatitis.Acta Odontol. Scand.28 , 1–8 (2009).
   Google Scholar
• Donnelly SM , SullivanDJ, ShanleyDB, ColemanDC: Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences.Microbiology145(8) , 1871–1882 (1999).
   PubMedGoogle Scholar
• Gilfillan GD , SullivanDJ, HaynesK, ParkinsonT, ColemanDC, GowNA: Candida dubliniensis: phylogeny and putative virulence factors.Microbiology144(4) , 829–838 (1998).
   PubMedGoogle Scholar
• Pinjon E , SullivanD, SalkinI, ShanleyD, ColemanD: Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans.J. Clin. Microbiol.36(7) , 2093–2095 (1998).
   PubMed Web of Science ®Google Scholar
• Pincus DH , ColemanDC, PruittWR et al.: Rapid identification of Candida dubliniensis with commercial yeast identification systems.J. Clin. Microbiol.37(11) , 3533–3539 (1999).
   PubMed Web of Science ®Google Scholar
• Al Mosaid A , SullivanD, SalkinIF, ShanleyD, ColemanDC: Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid–ferric citrate agar.J. Clin. Microbiol.39(1) , 323–327 (2001).
   PubMed Web of Science ®Google Scholar
• Mahmoudabadi AZ , RadcliffeCE, ColemanDC, DruckerDB: Comparison of Candida dubliniensis and C. albicans based on polar lipid composition.J. Appl. Microbiol.93(5) , 894–899 (2002).
   PubMed Web of Science ®Google Scholar
• Al Mosaid A , SullivanDJ, ColemanDC: Differentiation of Candida dubliniensis from Candida albicans on Pal‘s agar.J. Clin. Microbiol.41(10) , 4787–4789 (2003).
   PubMed Web of Science ®Google Scholar
• Moran G , StokesC, ThewesS, HubeB, ColemanDC, SullivanD: Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis.Microbiology150(10) , 3363–3382 (2004).
   PubMedGoogle Scholar
• Jackson AP , GambleJA, YeomansT et al.: Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans.Genome Res.19(12) , 2231–2244 (2009).
   PubMed Web of Science ®Google Scholar
• Stokes C , MoranGP, SpieringMJ, ColeGT, ColemanDC, SullivanDJ: Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans.Fungal Genet. Biol.44(9) , 920–931 (2007).
   PubMed Web of Science ®Google Scholar
• Moran GP , MacCallumDM, SpieringMJ, ColemanDC, SullivanDJ: Differential regulation of the transcriptional repressor NRG1 accounts for altered host–cell interactions in Candida albicans and Candida dubliniensis.Mol. Microbiol.66(4) , 915–929 (2007).
   PubMed Web of Science ®Google Scholar
• Enjalbert B , MoranGP, VaughanC et al.: Genome-wide gene expression profiling and a forward genetic screen show that differential expression of the sodium ion transporter Ena21 contributes to the differential tolerance of Candida albicans and Candida dubliniensis to osmotic stress.Mol. Microbiol.72(1) , 216–228 (2009).
   PubMed Web of Science ®Google Scholar
• Spiering MJ , MoranGP, ChauvelM et al.: Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model.Eukaryot. Cell9(2) , 251–265 (2010).
   PubMedGoogle Scholar
• Hazen KC : New and emerging yeast pathogens.Clin. Microbiol. Rev.8(4) , 462–478 (1995).
   PubMed Web of Science ®Google Scholar
• Rex JH , RinaldiMG, PfallerMA: Resistance of Candida species to fluconazole.Antimicrob. Agents Chemother.39(1) , 1–8 (1995).
   PubMed Web of Science ®Google Scholar
• Klepser ME , ErnstEJ, PfallerMA: Update on antifungal resistance.Trends Microbiol. (9) , 372–375 (1997).
   PubMed Web of Science ®Google Scholar
• White TC : Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.Antimicrob. Agents Chemother.41(7) , 1482–1487 (1997).
   PubMed Web of Science ®Google Scholar
• White TC , PfallerMA, RinaldiMG, SmithJ, ReddingSW: Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.Oral Dis.3(Suppl. 1) , 102–109 (1997).
   PubMedGoogle Scholar
• Müller FM , WeigM, PeterJ, WalshTJ: Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.J. Antimicrob. Chemother.46(2) , 338–340 (2000).
   PubMed Web of Science ®Google Scholar
• St-Germain G , LaverdièreM, PelletierR et al.: Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.J. Clin. Microbiol.39(3) , 949–953 (2001).
   PubMed Web of Science ®Google Scholar
• Vazquez JA , PengG, SobelJD et al.: Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.Clin. Infect. Dis.33(7) , 1069–1075 (2001).
   PubMed Web of Science ®Google Scholar
• Martínez M , López-RibotJL, KirkpatrickWR et al.: Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.J. Antimicrob. Chemother.49(3) , 515–524 (2002).
   PubMed Web of Science ®Google Scholar
• Morschhäuser J : The genetic basis of fluconazole resistance development in Candida albicans.Biochim. Biophys. Acta1587(2–3) , 240–248 (2002).
   PubMed Web of Science ®Google Scholar
• Pfaller MA , MesserSA, Boyken et al.: In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn. Microbiol. Infect. Dis.48(3) , 201–205 (2004).
   PubMed Web of Science ®Google Scholar
• Sanglard D , IscherF, CalabreseD, MajcherczykPA, BilleJ: The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.Antimicrob. Agents Chemother.43(11) , 2753–2765 (1999).
   PubMed Web of Science ®Google Scholar
• Hachem R , HannaH, KontoyiannisD, JiangY, RaadI: The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.Cancer112(11) , 2493–2499 (2008).
   PubMed Web of Science ®Google Scholar
• Pfaller MA , DiekemaDJ, GibbsDL et al.: Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.J. Clin. Microbiol.46(2) , 515–521 (2008).
   PubMed Web of Science ®Google Scholar
• Pfaller MA , MesserSA, HollisRJ: Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.Diagn. Microbiol. Infect. Dis.20(3) , 127–133 (1994).
   PubMed Web of Science ®Google Scholar
• Minari A , HachemR, RaadI: Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.Clin. Infect. Dis.32(2) , 186–190 (2001).
   PubMed Web of Science ®Google Scholar
• Hawkins JL , BaddourLM: Candida lusitaniae infections in the era of fluconazole availability.Clin. Infect. Dis.36(2) , E14–E18 (2003).
   PubMed Web of Science ®Google Scholar
• Chapeland-Leclerc F , BouchouxJ, GoumarA, ChastinC, VillardJ, NoëlT: Inactivation of the FCY2 gene encoding purine–cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.Antimicrob. Agents Chemother.49(8) , 3101–3108 (2005).
   PubMed Web of Science ®Google Scholar
• Florent M , NoëlT, Ruprich-RobertG et al.: Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.Antimicrob. Agents Chemother.53(7) , 2982–2990 (2009).
   PubMed Web of Science ®Google Scholar
• Joly S , PujolC, RyszM, VargasK, SollDR: Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis.J. Clin. Microbiol.37(4) , 1035–1044 (1999).
   PubMed Web of Science ®Google Scholar
• Al Mosaid A , SullivanDJ, PolacheckI et al.: Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.J. Clin. Microbiol.43(8) , 4026–4036 (2005).
   PubMed Web of Science ®Google Scholar
• Odds FC , BougnouxME, ShawDJ et al.: Molecular phylogenetics of Candida albicans.Eukaryot. Cell6(6) , 1041–1052 (2007).
   PubMedGoogle Scholar
• Tassel D , MadoffMA: Treatment of Candida sepsis and Cryptococcus meningitis with 5-fluorocytosine. A new antifungal agent.JAMA206(4) , 830–832 (1968).
   PubMed Web of Science ®Google Scholar
• Stiller RL , BennettJE, ScholerHJ, WallM, PolakA, StevensDA: Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model.J. Infect. Dis.147(6) , 1070–1077 (1983).
   PubMed Web of Science ®Google Scholar
• Vermes A , GuchelaarHJ, DankertJ: Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.J. Antimicrob. Chemother.46(2) , 171–179 (2000).
   PubMed Web of Science ®Google Scholar
• McManus BA , MoranGP, HigginsJA, SullivanDJ, ColemanDC: A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.Antimicrob. Agents Chemother.53(11) , 4678–4685 (2009).
   PubMed Web of Science ®Google Scholar
• Ahmad S , KhanZ, MokaddasE, KhanZU: Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait.J. Med. Microbiol.53(7) , 633–637 (2004).
   PubMed Web of Science ®Google Scholar
• Pfaller MA , MesserSA, BoykenL, HuynhH, HollisRJ, DiekemaDJ: In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.Antimicrob. Agents Chemother.46(11) , 3518–3521 (2002).
   PubMed Web of Science ®Google Scholar
• Quindós G , RuesgaMT, Martín-MazuelosE et al.: In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.Rev. Iberoam. Micol.21(2) , 63–69 (2004).
   PubMedGoogle Scholar
• Dodgson AR , DodgsonKJ, PujolC, PfallerMA, SollDR: Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans.Antimicrob. Agents Chemother.48(6) , 2223–2227 (2004).
   PubMed Web of Science ®Google Scholar
• Hope WW , TaberneroL, DenningDW, AndersonMJ: Molecular mechanisms of primary resistance to flucytosine in Candida albicans.Antimicrob. Agents Chemother.48(11) , 4377–4386 (2004).
   PubMed Web of Science ®Google Scholar
• Moran GP , SullivanDJ, HenmanMC et al.: Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.Antimicrob. Agents Chemother.41(3) , 617–623 (1997).
   PubMed Web of Science ®Google Scholar
• Pfaller MA , MesserSA, GeeS et al.: In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.J. Clin. Microbiol.37(3) , 870–872 (1999).
   PubMed Web of Science ®Google Scholar
• Chen SC , MarriottD, PlayfordEG et al.: Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.Clin. Microbiol. Infect.15(7) , 662–669 (2009).
   PubMed Web of Science ®Google Scholar
• Giammanco GM , PecorellaS, DistefanoS, PecoraroV, MiliciME, PizzoG: Fluconazole susceptibility of Italian Candida dubliniensis clinical isolates determined by reference and simplified tests.New Microbiol.24(4) , 397–404 (2001).
   PubMedGoogle Scholar
• Luque AG , BiasoliMS, ToselloME, BinolfiA, LupoS, MagaróHM: Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.Mycoses52(1) , 53–59 (2009).
   PubMed Web of Science ®Google Scholar
• Salgado-Parreño FJ , Alcoba-FlórezJ, AriasA: In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27-A2, Sensititre YeastOne, disk diffusion, and Etest methods.Microb. Drug Resist.12(4) , 246–251 (2006).
   PubMed Web of Science ®Google Scholar
• Moran GP , SanglardD, DonnellySM, ShanleyDB, SullivanDJ, ColemanDC: Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.Antimicrob. Agents Chemother.42(7) , 1819–1830 (1998).
   PubMed Web of Science ®Google Scholar
• Quindós G , Carrillo-MuñozAJ, ArévaloMP et al.: In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.Chemotherapy46(6) , 395–401 (2000).
   PubMed Web of Science ®Google Scholar
• Ruhnke M , Schmidt-WesthausenA, MorschhäuserJ: Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.J. Antimicrob. Chemother.46(2) , 291–295 (2000).
   PubMed Web of Science ®Google Scholar
• Kantarcioglu AS , YücelA: The presence of fluconazole-resistant Candida dubliniensis strains among Candida albicans isolates from immunocompromised or otherwise debilitated HIV-negative Turkish patients.Rev. Iberoam. Micol.19(1) , 44–48 (2002).
   PubMedGoogle Scholar
• Jewtuchowicz VM , MujicaMT, BruscaMI et al.: Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.Oral Microbiol. Immunol.23(6) , 505–509 (2008).
   PubMedGoogle Scholar
• Chunchanur SK , NadgirSD, HaleshLH, PatilBS, KausarY, ChandrasekharMR: Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.Indian J. Pathol. Microbiol.52(4) , 501–504 (2009).
   PubMed Web of Science ®Google Scholar
• Sanglard D , KuchlerK, IscherF, PaganiJL, MonodM, BilleJ: Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.Antimicrob. Agents Chemother.39(11) , 2378–2386 (1995).
   PubMed Web of Science ®Google Scholar
• Sanglard D , IscherF, MonodM, BilleJ: Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.Antimicrob. Agents Chemother.40(10) , 2300–2305 (1996).
   PubMed Web of Science ®Google Scholar
• Sanglard D , IscherF, MonodM, BilleJ: Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.Microbiology143(2) , 405–416 (1997).
   PubMedGoogle Scholar
• Wirsching S , MoranGP, SullivanDJ, ColemanDC, MorschhäuserJ: MDR1-mediated drug resistance in Candida dubliniensis.Antimicrob. Agents Chemother.45(12) , 3416–3421 (2001).
   PubMed Web of Science ®Google Scholar
• Moran G , SullivanD, MorschhäuserJ, ColemanD: The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.Antimicrob. Agents Chemother.46(9) , 2829–2841 (2002).
   PubMed Web of Science ®Google Scholar
• Pinjon E , JacksonCJ, KellySL et al.: Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.Antimicrob. Agents Chemother.49(4) , 1312–1318 (2005).
   PubMed Web of Science ®Google Scholar
• Franz R , KellySL, LambDC, KellyDE, RuhnkeM, MorschhäuserJ: Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.Antimicrob. Agents Chemother.42(12) , 3065–3072 (1998).
   PubMed Web of Science ®Google Scholar
• McManus BA , SullivanDJ, MoranGP et al.: Genetic differences between avian and human isolates of Candida dubliniensis.Emerg. Infect. Dis.15(9) , 1467–1470 (2009).
   PubMed Web of Science ®Google Scholar
• Selmecki A , ForcheA, BermanJ: Aneuploidy and isochromosome formation in drug-resistant Candida albicans.Science313(5785) , 367–370 (2006).
   PubMed Web of Science ®Google Scholar
• Coste A , SelmeckiA, ForcheA et al.: Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.Eukaryot. Cell6(10) , 1889–1904 (2007).
   PubMedGoogle Scholar
• Joly S , PujolC, SollDR: Microevolutionary changes and chromosomal translocations are more frequent at RPS loci in Candida dubliniensis than in Candida albicans.Infect. Genet. Evol.2(1) , 19–37 (2002).
   PubMed Web of Science ®Google Scholar
• Perea S , López-RibotJL, WickesBL et al.: Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.Antimicrob. Agents Chemother.46(6) , 1695–1703 (2002).
   PubMed Web of Science ®Google Scholar
• Sanglard D , IscherF, KoymansL, BilleJ: Amino acid substitutions in the cytochrome P-450 lanosterol 14a-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.Antimicrob. Agents Chemother.42(2) , 241–253 (1998).
   PubMed Web of Science ®Google Scholar
• Perea S , López-RibotJL, KirkpatrickWR et al.: Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.Antimicrob. Agents Chemother.45(10) , 2676–2684 (2001).
   PubMed Web of Science ®Google Scholar
• Morschhäuser J , BarkerKS, LiuTT, BlaB-WarmuthJ, HomayouniR, RogersPD: The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.PLoS Pathog.3(11) , e164 (2007).
   PubMed Web of Science ®Google Scholar
• Dunkel N , BlassJ, RogersPD, MorschhäuserJ: Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains.Mol. Microbiol.69(4) , 827–840 (2008).
   PubMed Web of Science ®Google Scholar
• Schubert S , RogersPD, MorschhäuserJ: Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.Antimicrob. Agents Chemother.52(12) , 4274–4280 (2008).
   PubMed Web of Science ®Google Scholar
• Fleischhacker M , PaslighJ, MoranG, RuhnkeM: Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution and the emergence of itraconazole resistance.J. Clin. Microbiol. (2010) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Pinjon E , MoranGP, JacksonCJ et al.: Molecular mechanisms of itraconazole resistance in Candida dubliniensis.Antimicrob. Agents Chemother.47(8) , 2424–2437 (2003).
   PubMed Web of Science ®Google Scholar
• Sanglard D , CosteA, FerrariS: Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.FEMS Yeast Res.9(7) , 1029–1050 (2009).
   PubMed Web of Science ®Google Scholar
• Morschhäuser J : Regulation of multidrug resistance in pathogenic fungi.Fungal Genet. Biol.47(2) , 94–106 (2010).
   PubMed Web of Science ®Google Scholar
• Melkusová S , BujdákováH, VollekováA, MyokenY, MikamiY: The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.Pharmazie59(7) , 573–574 (2004).
   PubMed Web of Science ®Google Scholar
• Pfaller MA , DiekemaDJ, MesserSA, BoykenL, HollisRJ, JonesRN: In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.Diagn. Microbiol. Infect. Dis.48(2) , 101–105 (2004).
   PubMed Web of Science ®Google Scholar
• Quindós G , Villar-VidalM, ErasoE: Activity of micafungin against Candida biofilms.Rev. Iberoam. Micol.26(1) , 49–55 (2009).
   PubMed Web of Science ®Google Scholar
• Szabo Z , BorbelyA, KardosG et al.: In vitro efficacy of amphotericin B, 5-fluorocytosine, fluconazole, voriconazole and posaconazole against Candida dubliniensis isolates using time-kill methodology.Mycoses (2010) (In Press).
   PubMed Web of Science ®Google Scholar
• Desnos-Ollivier M , BretagneS, RaouxD, HoinardD, DromerF, Dannaoui E; European Committee on Antibiotic Susceptibility Testing: Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob. Agents Chemother.52(9) , 3092–3098 (2008).
   PubMed Web of Science ®Google Scholar
• Wiederhold NP , GrabinskiJL, Garcia-EffronG, PerlinDS, LeeSA: Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.Antimicrob. Agents Chemother.52(11) , 4145–4148 (2008).
   PubMed Web of Science ®Google Scholar
• Garcia-Effron G , LeeS, ParkS, ClearyJD, PerlinDS: Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-β-D-glucan synthase: implication for the existing susceptibility breakpoint.Antimicrob. Agents Chemother.53(9) , 3690–3699 (2009).
   PubMed Web of Science ®Google Scholar
• McGovern E , FlemingP, CostiganC, DominguezM, ColemanDC, NunnJ: Oral health in Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED).Eur. Arch. Paediatr. Dent.9(4) , 236–244 (2008).
   PubMedGoogle Scholar

Website

• Sanger Institute: Candida dubliniensis sequencing. www.sanger.ac.uk/sequencing/Candida/dubliniensis/
   Google Scholar